The Precision Peptide Company Inc. (CSE:BPC)
Canada · Delayed Price · Currency is CAD | Market Cap | 21.19M +527.4% |
| Revenue (ttm) | 92.71K +2,116.4% |
| Net Income | -5.73M |
| EPS | -0.19 |
| Shares Out | 47.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.4600 |
| Previous Close | 0.4650 |
| Day's Range | 0.4600 - 0.4600 |
| 52-Week Range | 0.1750 - 0.5800 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 29, 2026 |
About CSE:BPC
The Precision Peptide Company Inc. manufactures and distributes plant-based patties and other food products in Canada. The company offers old fashioned ghee; energy gel; and plant-based patty; energy gel products, and munchie mix, as well as custom co-packing, private labelling, product development, and label, design, and regulatory services. It also provides peptide therapies for stress management, gut health, longevity, hair health, skin repair, and sleep health. It distributes its products through its websites, retail outlets, and wholesale ... [Read more]
Financial Performance
In fiscal year 2025, CSE:BPC's revenue was 49,720, an increase of 307.47% compared to the previous year's 12,202. Losses were -4.53 million, 339.0% more than in 2024.
Financial StatementsNews
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...
The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it intends to undertake a n...
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership
Highlights Signed an agreement with a U.S.-based prescription telehealth and infrastructure partner to support compliant prescribing, fulfillment, and delivery of the Company's peptide products Builds...
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, further to its news releas...
The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
Highlights Executed compounding agreement with a U.S.-based 503A sterile compounding pharmacy partner Compounding activities under the agreement expected to commence on Monday, June 1, 2026 All peptid...
The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
Highlights Only peptide company exhibiting at BEYOND 2026, Dave Asprey's flagship biohacking, longevity, and consciousness conference Three immersive days in Austin, Texas — May 27-29, 2026 5,000+ att...
The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
Highlights Order placed for 20,000 units of the Company's lead product candidate, a needle-free BPC-157 transdermal patch, in preparation for commercial release Initial commercial release of the BPC-1...
The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
Exclusive Agreement Gives Precision Direct Commercial Access to MMA.INC's Global Combat Sports Ecosystem, Backed by Strategic Advisors Conor McGregor and Donald Trump Jr., Cofounder John Kavanagh and ...
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
Highlights The BPC-157 patch is a wearable, needle-free product, designed to remove the injection barrier that has historically limited consumer adoption of peptide products Results support The Precis...
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced ...
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances
First wearable peptide patch designed to expand BPC-157 beyond injectables and establish a multi-product transdermal peptide platform under Amino Innovations Vancouver, British Columbia--(Newsfile Cor...
C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced pe...
The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced p...
The Precision Peptide Company Announces Strategic Product Marketing Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a stra...
The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-b...
The Precision Peptide Company Announces Public Relations and Consulting Services Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreem...
The Precision Peptide Company Launches New Corporate Website and Comments on Evolving U.S. Policy in Support of Peptide-Based Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-b...
Pangea Announces Name Change
Vancouver, BC – March 13, 2026 – TheNewswire - Pangea Wellness Inc. (“Pangea” or the “Company”) (CSE: PNGA) (OTC: PNGAF) announces that further to the Company's news release dated March 6, 2026, the e...
Pangea Announces Proposed Name Change
Vancouver, BC – March 6, 2026 – TheNewswire - Pangea Wellness Inc. (“ Pangea ” or the “ Company ”) (CSE: PNGA) (OTC: PNGAF) announces that subject to the approval of the Canadian Securities Exchange, ...
Amino Innovations Appoints Dave Asprey, Jim Gunning, and Travis Rosbach as Strategic Advisors to Support Brand Growth and Market Expansion
Vancouver, British Columbia – TheNewswire - December 5, 2025 – Pangea Wellness Inc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the “ Company ”), is pleased to announce that its subsidiary, Amino Innova...
Amino Innovations Launches Wholesale Program to Bring Human Peptide Science to Clinics, Retailers., and Wellness Centers Nationwide
Vancouver, British Columbia – December 2, 2025 – TheNewswire - Pangea Wellness Inc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the “ Company ”), is pleased to announce that its subsidiary, Amino Innovat...
Pangea Announces Filing of Amended and Restated Interim Financial Statements and Management's Discussion and Analysis
Vancouver, British Columbia – November 14, 2025 – TheNewswire - Pangea Natural Foods Inc. (CSE: PNGA) (OTC: PNGAF) (“Pangea” or the “Company”) announces that as a result of a continuous disclosure rev...
Amino Innovations Forms Strategic Research Partnership with University of Alberta Scientists to Advance Peptide Innovation
Vancouver, British Columbia – TheNewswire - October 23, 2025 – Pangea Natural Foods Inc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the “ Company ”), is pleased to announce that its wholly owned subsid...
Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Pangea Natural Foods Inc. (CSE:PNGA) (OTC: PNGAF) (" Pangea " or the " Company"), is excited to announce that its wholly owned subsidiary, Amino Innovations I...
Pangea Natural Foods Inc. Announces Closing of Private Placement and Debt Settlement and Corporate Update
VANCOUVER, BC – February 4, 2025 – TheNewswire – Pangea Natural Foods Inc. (the ‘Company' or ‘Pangea') (CSE: PNGA) (OTCQB: PNGAF), a manufacturer and co-packer of health food products, is pleased to a...